EGRX 0.9 (-54.77%)
US2697961082Drug ManufacturersDrug Manufacturers - Specialty & Generic

Eagle Pharmaceuticals (EGRX) Competitor Comparison

We are evaluating the key criteria listed to compare Eagle Pharmaceuticals (EGRX) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 3 years - EGRX ranking 33 / 54

These are the competitors of Eagle Pharmaceuticals in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 3 years
1. Kamada KMDA
132.38
2. Phibro Animal Health PAHC
46.81
3. Zoetis ZTS
46.75
4. Kolinpharma KIP.MI
11.59
5. Supernus Pharmaceuticals SUPN
10.23
6. Alimera Sciences ALIM
8.97
7. Alvotech ALVO
7.21
8. Vifor Pharma G2AB.F
6.24
9. Avadel Pharmaceuticals AVDL
5.83
10. ProPhase Labs PRPH
5.81
11. PetIQ PETQ
5.31
12. Perrigo PRGO
4.32
13. Taro Pharmaceutical Industries TARO
3.87
14. Cumberland Pharmaceuticals CPIX
3.84
15. Regencell Bioscience Holdings RGC
3.8
16. Pacira BioSciences PCRX
3.73
17. ANI Pharmaceuticals ANIP
3.61
18. Journey Medical DERM
3.2
19. Ironwood Pharmaceuticals IRWD
3.15
20. Catalent CTLT
3.04
21. Zynerba Pharmaceuticals ZYNE
3
22. Linc LNC
2.94
23. Elanco Animal Health ELAN
2.82
24. Green Thumb Industries R9U2.F
2.73
25. Cronos Group CRON
2.69
26. OptiNose OPTN
2.55
27. Embecta EMBC
2.52
28. SCYNEXIS SCYX
2.48
29. Societal CDMO SCTL
2.41
30. Procaps Group PROC
2.38
31. Curaleaf Holdings CURLF
2.23
32. Bausch Health Companies BHC
2.14
33. Eagle Pharmaceuticals EGRX
1.94
34. Organogenesis Holdings ORGO
1.92
35. Relmada Therapeutics RLMD
1.91
36. Amphastar Pharmaceuticals AMPH
1.89
37. Teva Pharmaceutical Industries TEVA
1.89
38. Jupiter Wellness JUPW
1.84
39. Theratechnologies THTX
1.83
40. Amneal Pharmaceuticals AMRX
1.81
41. Emergent BioSolutions EBS
1.81
42. Tilray Brands TLRY
1.81
43. Ascend Wellness Holdings AAWH
1.76
44. Flora Growth FLGC
1.74
45. Universe Pharmaceuticals UPC
1.74
46. Solid Biosciences SLDB
1.71
47. Biofrontera BFRI
1.68
48. Alpha Teknova TKNO
1.66
49. Neoleukin Therapeutics NLTX
1.57
50. Clever Leaves Holdings CLVR
1.47
51. Ayr Wellness 3KJB.F
1.45
52. Collegium Pharmaceutical COLL
1.31
53. Evolus EOLS
1.14
54. Harrow Health HROW
0.4

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.